Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Thromboprophylaxis in lower limb immobilisation after injury (TiLLI).

Horner D, Goodacre S, Pandor A, Nokes T, Keenan J, Hunt B, Davis S, Stevens JW, Hogg K.

Emerg Med J. 2019 Nov 6. pii: emermed-2019-208944. doi: 10.1136/emermed-2019-208944. [Epub ahead of print]

2.

Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta-analysis.

Horner D, Stevens JW, Pandor A, Nokes T, Keenan J, de Wit K, Goodacre S.

J Thromb Haemost. 2019 Oct 26. doi: 10.1111/jth.14666. [Epub ahead of print]

PMID:
31654551
3.

Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies.

Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Kearney M, Stevens JW, Benedict A, Bharmal M.

Pharmacoeconomics. 2019 Dec;37(12):1537-1551. doi: 10.1007/s40273-019-00831-3.

PMID:
31555968
4.

Adalimumab for non-infectious uveitis: is it cost-effective?

Bermejo I, Squires H, Poku EN, Cooper K, Stevens JW, Hamilton J, Wong R, Pearce I, Quhill FM, Denniston AK.

Br J Ophthalmol. 2019 Nov;103(11):1633-1638. doi: 10.1136/bjophthalmol-2018-312756. Epub 2019 Feb 6.

5.

Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.

Simpson EL, Ren S, Hock ES, Stevens JW, Binard A, Pers YM, Archer R, Paisley S, Stevenson MD, Herpin C, Ghabri S.

Int J Technol Assess Health Care. 2019 Jan;35(1):36-44. doi: 10.1017/S0266462318003628. Epub 2019 Feb 6.

6.

Decision-analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury.

Davis S, Goodacre S, Pandor A, Horner D, Stevens JW, de Wit K, Hunt BJ.

Br J Haematol. 2019 Jul;186(1):166-168. doi: 10.1111/bjh.15748. Epub 2019 Jan 29. No abstract available.

PMID:
30697707
7.

Estimating Future Health Technology Diffusion Using Expert Beliefs Calibrated to an Established Diffusion Model.

Grimm SE, Stevens JW, Dixon S.

Value Health. 2018 Aug;21(8):944-950. doi: 10.1016/j.jval.2018.01.010. Epub 2018 Mar 5.

8.
9.

Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses.

Ren S, Oakley JE, Stevens JW.

Med Decis Making. 2018 May;38(4):531-542. doi: 10.1177/0272989X18759488. Epub 2018 Mar 29.

10.

Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rafia R, Pandor A, Davis S, Stevens JW, Harnan S, Clowes M, Sorour Y, Cutting R.

Pharmacoeconomics. 2018 Oct;36(10):1143-1151. doi: 10.1007/s40273-018-0645-2. Review.

11.

A review of methods for comparing treatments evaluated in studies that form disconnected networks of evidence.

Stevens JW, Fletcher C, Downey G, Sutton A.

Res Synth Methods. 2018 Jun;9(2):148-162. doi: 10.1002/jrsm.1278. Epub 2017 Dec 17. Review.

12.

5'-methylschweinfurthin G reduces chondrosarcoma tumor growth .

Stevens JW, Meyerholz DK, Neighbors JD, Morcuende JA.

J Orthop Res. 2018 Apr;36(4):1283-1293. doi: 10.1002/jor.23753. Epub 2017 Nov 21.

13.

Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Squires H, Pandor A, Thokala P, Stevens JW, Kaltenthaler E, Clowes M, Coleman R, Wyld L.

Pharmacoeconomics. 2018 Jan;36(1):29-38. doi: 10.1007/s40273-017-0556-7. Review.

14.

Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Bermejo I, Stevenson M, Archer R, Stevens JW, Goka E, Clowes M, Scott DL, Young A.

Pharmacoeconomics. 2017 Nov;35(11):1141-1151. doi: 10.1007/s40273-017-0521-5. Review.

15.

The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate.

Stevenson MD, Wailoo AJ, Tosh JC, Hernandez-Alava M, Gibson LA, Stevens JW, Archer RJ, Simpson EL, Hock ES, Young A, Scott DL.

J Rheumatol. 2017 Jul;44(7):973-980. doi: 10.3899/jrheum.160941. Epub 2017 Feb 15. Review.

16.

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M.

Pharmacoeconomics. 2017 Aug;35(8):805-815. doi: 10.1007/s40273-017-0488-2. Review.

17.

Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation Dynamics.

Grimm SE, Dixon S, Stevens JW.

Med Decis Making. 2017 Jul;37(5):523-533. doi: 10.1177/0272989X16686766. Epub 2017 Jan 6.

18.

When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices.

Grimm SE, Dixon S, Stevens JW.

Value Health. 2016 Sep - Oct;19(6):720-726. doi: 10.1016/j.jval.2016.06.002. Epub 2016 Aug 21.

19.
20.

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

Thokala P, Simpson EL, Tappenden P, Stevens JW, Dickinson K, Ryder S, Harrison P.

Pharmacoeconomics. 2016 Aug;34(8):741-50. doi: 10.1007/s40273-016-0387-y. Review.

21.

Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluation.

Pandor A, Thokala P, Goodacre S, Poku E, Stevens JW, Ren S, Cantrell A, Perkins GD, Ward M, Penn-Ashman J.

Health Technol Assess. 2015 Jun;19(42):v-vi, 1-102. doi: 10.3310/hta19420. Review.

22.

Regulation of thrombosis and vascular function by protein methionine oxidation.

Gu SX, Stevens JW, Lentz SR.

Blood. 2015 Jun 18;125(25):3851-9. doi: 10.1182/blood-2015-01-544676. Epub 2015 Apr 21. Review.

23.

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY.

Pharmacoeconomics. 2015 Aug;33(8):833-47. doi: 10.1007/s40273-015-0272-0. Review.

24.

Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.

Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E.

Diabetes Res Clin Pract. 2015 Mar;107(3):320-31. doi: 10.1016/j.diabres.2015.01.027. Epub 2015 Jan 21. Review.

PMID:
25638454
25.

The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards.

Wailoo AJ, Stevenson M, Tosh J, Hernández M, Stevens JW, Archer R, Simpson E, Everson HE, Scott D, Young A, Paisley S, Williams K.

Value Health. 2014 Nov;17(7):A380. doi: 10.1016/j.jval.2014.08.2611. Epub 2014 Oct 26. No abstract available.

26.

Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk: A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions.

Stevens JW, Harvey RC, Johnson M, Khunti K.

Value Health. 2014 Nov;17(7):A335. doi: 10.1016/j.jval.2014.08.643. Epub 2014 Oct 26. No abstract available.

27.

Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysis.

Goodacre S, Stevens JW, Pandor A, Poku E, Ren S, Cantrell A, Bounes V, Mas A, Payen D, Petrie D, Roessler MS, Weitz G, Ducros L, Plaisance P.

Acad Emerg Med. 2014 Sep;21(9):960-70. doi: 10.1111/acem.12466. Review.

28.

Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.

Dayal S, Blokhin IO, Erger RA, Jensen M, Arning E, Stevens JW, Bottiglieri T, Faraci FM, Lentz SR.

PLoS One. 2014 Sep 16;9(9):e107734. doi: 10.1371/journal.pone.0107734. eCollection 2014.

29.

Osteoclast inhibition impairs chondrosarcoma growth and bone destruction.

Otero JE, Stevens JW, Malandra AE, Fredericks DC, Odgren PR, Buckwalter JA, Morcuende J.

J Orthop Res. 2014 Dec;32(12):1562-71. doi: 10.1002/jor.22714. Epub 2014 Aug 13.

30.

Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.

Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Cantrell A, Michaels J.

Br J Surg. 2014 Aug;101(9):1040-52. doi: 10.1002/bjs.9566. Epub 2014 Jun 25. Review.

31.

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.

Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A.

Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330. Review.

32.

Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).

Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.

Br J Surg. 2013 Dec;100(13):1838-9. doi: 10.1002/bjs.9358. No abstract available.

PMID:
24227373
33.

Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation.

Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Everson-Hock E, Cantrell A, Stevenson M, Michaels J.

Health Technol Assess. 2013 Oct;17(48):i-xvi, 1-141. doi: 10.3310/hta17480. Review.

34.

Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs.

Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J, Cowie MR, Wong R.

BMJ Open. 2013 Sep 18;3(9):e003250. doi: 10.1136/bmjopen-2013-003250.

35.

Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.

Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A, Fitzgerald P.

Health Technol Assess. 2013 Aug;17(32):1-207, v-vi. doi: 10.3310/hta17320. Review.

36.

Swarm chondrosarcoma: a continued resource for chondroblastic-like extracellular matrix and chondrosarcoma biology research.

Stevens JW.

Connect Tissue Res. 2013;54(4-5):252-9. doi: 10.3109/03008207.2013.806913. Epub 2013 Jun 28. Review.

PMID:
23758266
37.

Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis.

Pandor A, Gomersall T, Stevens JW, Wang J, Al-Mohammad A, Bakhai A, Cleland JG, Cowie MR, Wong R.

Heart. 2013 Dec;99(23):1717-26. doi: 10.1136/heartjnl-2013-303811. Epub 2013 May 16. Review.

PMID:
23680885
38.

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisal.

Tosh J, Archer R, Davis S, Stevenson M, Stevens JW.

Pharmacoeconomics. 2013 Aug;31(8):653-61. doi: 10.1007/s40273-013-0052-7. Review.

PMID:
23576019
39.

Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.

Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G, O'Donnell ME.

Angiology. 2014 Mar;65(3):190-7. doi: 10.1177/0003319712474335. Epub 2013 Jan 31.

PMID:
23378195
40.

Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.

Goodacre S, Thokala P, Carroll C, Stevens JW, Leaviss J, Al Khalaf M, Collinson P, Morris F, Evans P, Wang J.

Health Technol Assess. 2013;17(1):v-vi, 1-188. doi: 10.3310/hta17010. Review.

41.

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.

Br J Surg. 2012 Dec;99(12):1630-8. doi: 10.1002/bjs.8895. Epub 2012 Oct 3. Review.

PMID:
23034699
42.

Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction.

Thokala P, Goodacre SW, Collinson PO, Stevens JW, Mills NL, Newby DE, Morris F, Kendall J, Stevenson MD.

Heart. 2012 Oct;98(20):1498-503. Epub 2012 Aug 3.

PMID:
22865867
43.

Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis.

Carroll C, Al Khalaf M, Stevens JW, Leaviss J, Goodacre S, Collinson PO, Wang J.

Emerg Med J. 2013 Apr;30(4):280-6. doi: 10.1136/emermed-2012-201174. Epub 2012 May 16. Review.

PMID:
22593266
44.

Trabectedin for the treatment of relapsed ovarian cancer.

Papaioannou D, Rafia R, Stevenson MD, Stevens JW, Evans P.

Health Technol Assess. 2011 May;15 Suppl 1:69-75. doi: 10.3310/hta15suppl1/08. Review.

45.

Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.

Malchenko S, Seftor EA, Nikolsky Y, Hasegawa SL, Kuo S, Stevens JW, Poyarkov S, Nikolskaya T, Kucaba T, Wang M, Abdulkawy H, Casavant T, Morcuende J, Buckwalter J, Hohl R, Deyoung B, Kernstine K, Bonaldo Mde F, Hendrix MJ, Soares MB, Soares VM.

Sarcoma. 2012;2012:820254. doi: 10.1155/2012/820254. Epub 2012 Feb 16.

46.

Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice.

Khan MM, Gandhi C, Chauhan N, Stevens JW, Motto DG, Lentz SR, Chauhan AK.

Stroke. 2012 May;43(5):1376-82. doi: 10.1161/STROKEAHA.111.635516. Epub 2012 Feb 23.

47.

Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Turner RM, Lloyd-Jones M, Anumba DO, Smith GC, Spiegelhalter DJ, Squires H, Stevens JW, Sweeting MJ, Urbaniak SJ, Webster R, Thompson SG.

PLoS One. 2012;7(2):e30711. doi: 10.1371/journal.pone.0030711. Epub 2012 Feb 3.

48.

Swarm rat chondrosarcoma cells as an in vivo model: lung colonization and effects of tissue environment on tumor growth.

Morcuende JA, Stevens JW, Scheetz TE, de Fatima Bonaldoc M, Casavant TL, Otero JE, Soares MB.

Iowa Orthop J. 2012;32:46-53.

49.

A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.

Squires H, Simpson E, Meng Y, Harnan S, Stevens J, Wong R, Thomas S, Michaels J, Stansby G.

Health Technol Assess. 2011 Dec;15(40):1-210. doi: 10.3310/hta15400. Review.

50.

Pharmaceutical Statistics 10th anniversary.

Hutchinson K, Stevens JW.

Pharm Stat. 2011 Nov-Dec;10(6):475-6. doi: 10.1002/pst.534. Epub 2011 Dec 2. No abstract available.

PMID:
22135194

Supplemental Content

Loading ...
Support Center